This case report aimed to describe haemostatic agents with systemic methotrexate (MTX) as an effective management for cervical pregnancy with bleeding.
A 34-year-old nulligravida patient was referred due to vaginal spotting and lower abdominal discomfort, and was diagnosed with a cervical pregnancy at 6 weeks of gestation. The patient was treated with a multi-dose MTX regimen, and the bleeding was successfully controlled with haemostatic agents, which were applied at the bleeding site of the cervix. After completion of MTX treatment, beta human chorionic gonadotropin (β-hCG) decreased to undetectable range. Furthermore, patients could preserve her uterus and maintain fertility.
Haemostatic agents can be regarded as an effective option for vaginal bleeding due to cervical pregnancy.
病例介绍：一名34岁的未孕妇女因阴道点滴出血和下腹部不适而转诊, 并在怀孕6周时被诊断为宫颈妊娠。患者接受MTX多剂量方案治疗, 宫颈出血部位应用止血剂止血成功。甲氨蝶呤治疗结束后, β-人绒毛膜促性腺激素(β-hCG)降至检测范围下线以下。此外, 患者可保留子宫和生育能力。
No potential conflict of interest was reported by the author(s).